Literature DB >> 22482933

Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm?

Peter G Rose.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22482933     DOI： 10.1016/j.ygyno.2012.03.010

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  7 in total

1.  Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in control of cervical squamous cell carcinoma than that of cervical adenocarcinoma.

Authors:  Yanli Xiong; Jia Liu; Shu Chen; Qian Zhou; Wenjing Xu; Chen Tang; Yonghong Chen; Mei Yang; Xin Lei
Journal:  Med Oncol       Date:  2015-08-14       Impact factor: 3.064

Review 2.  Recent advances in invasive adenocarcinoma of the cervix.

Authors:  Simona Stolnicu; Lien Hoang; Robert A Soslow
Journal:  Virchows Arch       Date:  2019-06-17       Impact factor: 4.064

3.  Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.

Authors:  Vivian M Spaans; Marjolijn D Trietsch; Alexander A W Peters; Michelle Osse; Natalja Ter Haar; Gert J Fleuren; Ekaterina S Jordanova
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.

Authors:  Simone Punt; Marjolein E van Vliet; Vivian M Spaans; Cornelis D de Kroon; Gert Jan Fleuren; Arko Gorter; Ekaterina S Jordanova
Journal:  Cancer Immunol Immunother       Date:  2015-03-21       Impact factor: 6.968

5.  Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update.

Authors:  Fabio Landoni; Alessandro Colombo; Rodolfo Milani; Franco Placa; Vanna Zanagnolo; Costantino Mangioni
Journal:  J Gynecol Oncol       Date:  2017-02-24       Impact factor: 4.401

6.  Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients.

Authors:  Joanna Jonska-Gmyrek; Leszek Gmyrek; Agnieszka Zolciak-Siwinska; Maria Kowalska; Malgorzata Fuksiewicz; Beata Kotowicz
Journal:  Cancer Manag Res       Date:  2018-11-22       Impact factor: 3.989

7.  HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.

Authors:  Vivian M Spaans; Alexander A W Peters; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  J Transl Med       Date:  2012-09-04       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.